By EDITORIALMore by this AuthorThe choice of Kenya among three African countries to pilot a malaria vaccine is a welcome development. It is a recognition by the World Health Organisation of the enormous disease challenge, but most importantly, the efforts being made by the government and other organisations to fight malaria. Mosquirix, which according to the WHO, is the only vaccine developed against malaria that has reached the large-scale testing phase, will besides Kenya, be used in Ghana and Malawi from next year. This high-profile support that comes with adequate funding is something the health authorities must take full advantage of in the effort to roll back malaria. It remains a major problem in the coastal, and Lake Victoria regions and parts of Rift Valley.

Source: Daily Nation April 25, 2017 18:11 UTC